S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
Roku stock and the mother of all entry opportunities
Rivian shares gets discounted; shares can move lower 
My wife was skeptical... until I showed her my account balance. (Ad)
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
The Trade Desk: 3 reasons to buy before a new all-time high
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
Roku stock and the mother of all entry opportunities
Rivian shares gets discounted; shares can move lower 
My wife was skeptical... until I showed her my account balance. (Ad)
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
The Trade Desk: 3 reasons to buy before a new all-time high
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
Roku stock and the mother of all entry opportunities
Rivian shares gets discounted; shares can move lower 
My wife was skeptical... until I showed her my account balance. (Ad)
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
The Trade Desk: 3 reasons to buy before a new all-time high
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE! (Ad)
Roku stock and the mother of all entry opportunities
Rivian shares gets discounted; shares can move lower 
My wife was skeptical... until I showed her my account balance. (Ad)
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
The Trade Desk: 3 reasons to buy before a new all-time high
NASDAQ:ACHV

Achieve Life Sciences (ACHV) Stock Price, News & Analysis

$3.82
-0.18 (-4.50%)
(As of 02/22/2024 ET)
Today's Range
$3.82
$4.00
50-Day Range
$3.18
$5.14
52-Week Range
$3.03
$10.30
Volume
45,470 shs
Average Volume
47,677 shs
Market Capitalization
$80.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.00

Achieve Life Sciences MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
397.4% Upside
$19.00 Price Target
Short Interest
Bearish
3.17% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.18mentions of Achieve Life Sciences in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.57) to ($1.34) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.48 out of 5 stars

Medical Sector

718th out of 934 stocks

Diagnostic Substances Industry

9th out of 13 stocks


ACHV stock logo

About Achieve Life Sciences Stock (NASDAQ:ACHV)

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

ACHV Stock Price History

ACHV Stock News Headlines

Dangerous Bank Change (3 steps to protect yourself)
In July of this year, the US government made a sweeping change to bank accounts nationwide.  It gave them unheard-of powers to control your bank account. They can now closely track every transaction. They could even freeze it. Unless you protect yourself today. Fortunately, there are 3 simple steps you can take to safeguard your savings.
How to Achieve Work-Life Balance
Something is Coming for America's Top Stock
This stock has already doubled this year - but it could hurt your portfolio if you hold it much longer. Learn why here.
ACHV: Not So Fast…
Why Is Achieve Life Sciences (ACHV) Stock Down 44% Today?
Why Is Achieve Life Sciences (ACHV) Stock Down 25% Today?
See More Headlines
Receive ACHV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Achieve Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/16/2023
Today
2/22/2024
Next Earnings (Estimated)
3/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ACHV
CUSIP
68230A10
Employees
20
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$19.00
High Stock Price Target
$20.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+397.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-42,350,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.46 per share

Miscellaneous

Free Float
20,743,000
Market Cap
$80.87 million
Optionable
Optionable
Beta
1.45
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. Richard A. B. Stewart (Age 65)
    Executive Chairman
    Comp: $575k
  • Mr. John A. Bencich M.B.A. (Age 47)
    CEO & Director
    Comp: $733.12k
  • Dr. Cindy Jacobs M.D. (Age 66)
    Ph.D., President, Chief Medical Officer & Director
    Comp: $614.25k
  • Mr. Jerry Wan (Age 42)
    Principal Accounting Officer
  • Dr. Anthony Clarke (Age 68)
    Chief Scientific Officer
    Comp: $546k
  • Ms. Jaime Xinos
    Executive Vice President of Commercial














ACHV Stock Analysis - Frequently Asked Questions

Should I buy or sell Achieve Life Sciences stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Achieve Life Sciences in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ACHV shares.
View ACHV analyst ratings
or view top-rated stocks.

What is Achieve Life Sciences' stock price target for 2024?

2 Wall Street analysts have issued 12-month price targets for Achieve Life Sciences' stock. Their ACHV share price targets range from $18.00 to $20.00. On average, they predict the company's stock price to reach $19.00 in the next twelve months. This suggests a possible upside of 397.4% from the stock's current price.
View analysts price targets for ACHV
or view top-rated stocks among Wall Street analysts.

How have ACHV shares performed in 2024?

Achieve Life Sciences' stock was trading at $4.12 on January 1st, 2024. Since then, ACHV shares have decreased by 7.3% and is now trading at $3.82.
View the best growth stocks for 2024 here
.

When is Achieve Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 21st 2024.
View our ACHV earnings forecast
.

How were Achieve Life Sciences' earnings last quarter?

Achieve Life Sciences, Inc. (NASDAQ:ACHV) issued its earnings results on Thursday, March, 16th. The biopharmaceutical company reported ($0.83) earnings per share for the quarter, beating the consensus estimate of ($0.90) by $0.07. During the same period in the previous year, the business earned ($0.76) earnings per share.

When did Achieve Life Sciences' stock split?

Achieve Life Sciences shares reverse split on the morning of Friday, July 31st 2020. The 1-20 reverse split was announced on Thursday, July 30th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 30th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Achieve Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Achieve Life Sciences investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Gran Tierra Energy (GTE), Bionano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), KushCo (KSHB) and Pennsylvania Real Estate Investment Trust (PEI).

Who are Achieve Life Sciences' major shareholders?

Achieve Life Sciences' stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (2.86%), Raymond James & Associates (0.73%), Northern Trust Corp (0.48%), Madison Park Capital Advisors LLC (0.05%), Simplex Trading LLC (0.00%) and Citadel Advisors LLC (0.00%).
View institutional ownership trends
.

How do I buy shares of Achieve Life Sciences?

Shares of ACHV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ACHV) was last updated on 2/23/2024 by MarketBeat.com Staff